MS
Munender Soperna Dirigeant
Other
IN IN · SEBI (PIT + SAST)
Explore the complete record of transactions filed by Munender Soperna, Dirigeant. Officer active across 1 companies, notably Dr. Lal Path Labs Ltd.. In total, 32 reports have been logged. The latest transaction was filed on 30 August 2024 — Sale. Regulator: SEBI (PIT + SAST). The full history is accessible without signup.
Declarations 32 total
€18,272 500 shares @ €36.5432
Equity Shares
SEBI:d4076133321f5d02dabb4675cee5d21b6ec6fbdf · 30 Aug 2024
€113,393 3,180 shares @ €35.6581
Equity Shares
SEBI:2756b9484db273dfae9af3cbfc772cf5eb7e6bb9 · 16 Aug 2024
€17,404 500 shares @ €34.8077
Equity Shares
SEBI:cebf33d81340ab67d8512a7dc6915c44583fb4d7 · 14 Aug 2024
€15,385 500 shares @ €30.7692
Equity Shares
SEBI:00c3156ddbc767c4727816e6686b14829e416551 · 7 Jun 2024
€12,756 400 shares @ €31.8912
Equity Shares
SEBI:9b0c9426375a5829985794881da0548f9a7de3aa · 10 Jun 2024
€30,305 1,000 shares @ €30.305
Equity Shares
SEBI:653a80d575be467419de74b79ef44bef0bd7504d · 5 Jun 2024
€28,851 1,000 shares @ €28.8509
Equity Shares
SEBI:66c21c3a6b6920b66487793fd5a6acca928960ed · 28 May 2024
€94 850 shares @ €0.1108
Equity Shares
SEBI:23d32bbedc569447020b3ffd83a580f4c7002223 · 27 Mar 2024
Ideal exit: 22 Dec 2024 (T+270) €205 1,875 shares @ €0.1095
Equity Shares
SEBI:bf922ee7ebd659e1d1a005bca9a5da868fa0341a · 18 Mar 2024
Ideal exit: 13 Dec 2024 (T+270) €32,903 1,200 shares @ €27.4196
Equity Shares
SEBI:f977b578034c4eff3ed7f9d336bb0a5e0626be64 · 23 Feb 2024
€21,990 800 shares @ €27.488
Equity Shares
SEBI:8d5fb6c2414281ef13e692fb607c66a165ada6d0 · 23 Feb 2024
€3,007 107 shares @ €28.1009
Equity Shares
SEBI:cef233886d735483476b1dc37f864943f323bd3d · 20 Feb 2024
€417 3,750 shares @ €0.1111
Equity Shares
SEBI:bacc6a2c4b63d1c2c30b2ae1ec751732b78b98c8 · 27 Feb 2024
Ideal exit: 23 Nov 2024 (T+270) €1,166 10,425 shares @ €0.1118
Equity Shares
SEBI:0f88a8fb89944d6f520c437e2cacf89a32b18421 · 9 Feb 2024
Ideal exit: 5 Nov 2024 (T+270) €29,902 1,000 shares @ €29.9021
Equity Shares
SEBI:a3ec96b5043bd5f8e0c589e35490dd543f8e7700 · 21 Nov 2023
€30,404 1,000 shares @ €30.404
Equity Shares
SEBI:63afcfe0b2faaf8531c8d6341d0cfe53f20996c7 · 16 Nov 2023
€27,667 987 shares @ €28.0309
Equity Shares
SEBI:e5f8009a9e32863721f0aa81fb65265f3d672fc1 · 29 Sept 2023
€20,349 800 shares @ €25.4358
Equity Shares
SEBI:eac825ac79b3ced016375f745abdfeff66540d46 · 25 Aug 2023
€17,492 700 shares @ €24.9879
Equity Shares
SEBI:d3ee1f8a6db2eb226a73ecf43d4405da02ad6b90 · 14 Aug 2023
€11,668 450 shares @ €25.9283
Equity Shares
SEBI:4805928d321abe90c2bd405eb2f3177c43bc9104 · 10 Aug 2023
€108 950 shares @ €0.1139
Equity Shares
SEBI:78149e9b18de1d916f9ee4e31b8dd4f84f8e46ce · 28 Feb 2023
Ideal exit: 25 Nov 2023 (T+270) €113 1,000 shares @ €0.1125
Equity Shares
SEBI:39cd74fd0e0d2c7baca46b7d298a64182f9ba384 · 7 Feb 2023
Ideal exit: 4 Nov 2023 (T+270) €129 1,125 shares @ €0.115
Equity Shares
SEBI:02eeab91e9ce939ecceda971abadcbad55a8c4a5 · 6 Jan 2023
Ideal exit: 3 Oct 2023 (T+270) €77 625 shares @ €0.1235
Equity Shares
SEBI:904541b08b462c9aa1ffdc79d0f467c550c71eae · 26 Jul 2022
Ideal exit: 22 Apr 2023 (T+270) €60 500 shares @ €0.121
Equity Shares
SEBI:560add301601271c3075e0db9927d18fd7a18cc6 · 22 Jun 2022
Ideal exit: 19 Mar 2023 (T+270) 25 of 32 declarations
Load more (7 remaining) About Munender Soperna Munender Soperna is an executive at Dr. Lal Path Labs Ltd., where he contributes to managing operations and developing diagnostic services. His role is essential in ensuring quality and innovation in the services offered.